Bausch Health reported strong Q4 results with a 6.2% Y/Y revenue increase and positive net income, driving a 10% stock rally.

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

The NBA is suspending big man Bobby Portis Jr. for 25 games for violating the terms of the NBA/NBPA Anti-Drug Program, the ...

Galapagos shifts to CAR-T therapy with GLPG5101, targeting pivotal trials by 2026. Click here to find out why I rate GLPG ...

The NBA has suspended Milwaukee forward Bobby Portis Jr. for 25 games without pay because he tested positive for the painkiller Tramadol, a violation of the league’s anti-drug program ...

Milwaukee Bucks forward Bobby Portis Jr. is facing a 25-game suspension for violating the NBA's anti-drug policy, according ...

Thank goodness for pharmacies around the country taking matters into their own hands. According to the BioPharma Dive website, Trump’s move—or should I say Elon Musk’s move—to drastically reduce the ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The market's underestimating how well each of these companies should be able to capitalize on their opportunities.

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.